Drug recall D-0591-2021
Product
Briviact (brivaracetam) tablets 50 mg, 60-count bottle, Rx only Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-570-66
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
309750
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 101 bottles
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Briviact – drug information
- NDC 50474-870 Briviact · Brivaracetam 10 mg/mL · UCB, Inc.
- NDC 50474-970 Briviact · Brivaracetam 50 mg/5mL · UCB, Inc.
- NDC 50474-570 Briviact · Brivaracetam 50 mg/1 · UCB, Inc.
- NDC 50474-670 Briviact · Brivaracetam 75 mg/1 · UCB, Inc.
- NDC 50474-370 Briviact · Brivaracetam 10 mg/1 · UCB, Inc.
- NDC 50474-770 Briviact · Brivaracetam 100 mg/1 · UCB, Inc.
- NDC 50474-470 Briviact · Brivaracetam 25 mg/1 · UCB, Inc.